← Back to Clinical Trials
Recruiting NCT05907681
Prospective Observational Study on Outcome of High-precision Hypo-fractionated Radiotherapy in Metastatic Breast Cancer (PRECISE-M)
Trial Parameters
Condition Breast Cancer
Sponsor Samsung Medical Center
Study Type OBSERVATIONAL
Phase N/A
Enrollment 400
Sex FEMALE
Min Age 19 Years
Max Age 100 Years
Start Date 2023-05-11
Completion 2028-12-31
All Conditions
Brief Summary
This study is a prospective observational study on outcomes of high precision hypo-fractionated radiotherapy in breast cancer with distant metastasis.
Eligibility Criteria
Inclusion Criteria: * histologically confirmed breast cancer * presence of distant metastasis * radiation therapy using IMRT, SBRT, or proton therapy is done or planned * Able and willing to comply with the study protocol Exclusion Criteria: * unable to adhere to the study protocol
Related Trials
NCT05573893
PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Rea
View Trial →
NCT04965064
Trial of Neratinib Plus Capecitabine in Subjects With HER2-Negative Metastatic Breast Cancer With Br
View Trial →
NCT03449264
Development of Clinical and Biological Database
View Trial →